Solution structure of human survivin and its binding interface with Smac/Diablo

Biochemistry

Volumn 44, Issue 1, 2005, Pages 11-17

  Sun, Chaohong ^a   Nettesheim, David ^a   Liu, Zhihong ^a   Olejniczak, Edward T ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL STRUCTURE; DIMERS; INTERFACES (MATERIALS); NUCLEAR MAGNETIC RESONANCE; PERTURBATION TECHNIQUES; X RAY ANALYSIS;

BINDING INTERFACES; BOW-TIE-SHAPED DIMERS; HOMODIMER INTERFACE; SOLUTION STRUCTURE;

PROTEINS;

DIMER; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DIMERIZATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RESIDUE ANALYSIS; SOLUTION AND SOLUBILITY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BINDING SITES; CARRIER PROTEINS; DIMERIZATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIAL PROTEINS; MODELS, MOLECULAR; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SOLUTIONS;

EID: 11844252553     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0485171     Document Type: Article

References (36)

1. Altieri, D. C. (2003) Survivin, versatile modulation of cell division and apoptosis in cancer, Oncogene 22, 8581-8589.
2. Altieri, D. C. (2003) Validating survivin as a cancer therapeutic target, Nat. Rev. Cancer 3, 46-54.
3. Salvesen, G. S., and Duckett, C. S. (2002) 1AP proteins: Blocking the road to death's door, Nat. Rev. Mol. Cell Biol. 401-410.
4. Fesik, S. W., and Shi, Y. G. (2001) Structural biology - Controlling the caspases, Science 294, 1477-1478.
5. Shi, Y. G. (2002) Mechanisms of caspase activation and inhibition during apoptosis, Mol. Cell 9, 459-470.
6. Blanc Brude, O. P., Mesri, M., Wall, N. R., Plescia, J., Dohi, T., and Altieri, D. C. (2003) Therapeutic targeting of the survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis, Clin. Cancer Res. 9, 2683-2692.
7. Marusawa, H., Matsuzawa, S., Welsh, K., Zou, H., Armstrong, R., Tamm, I., and Reed, J. C. (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression, EMBO J. 22, 2729-2740.
8. Song, Z. Y., Yao, X. B., and Wu, M. (2003) Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis, J. Biol. Chem 278, 23130-23140.
9. Adams, R. R., Carmena, M., and Earnshaw, W. C. (2001) Chromosomal passengers and the (aurora) ABCs of mitosis, Trends Cell Biol. 11, 49-54.
10. Reed, J. C., and Bischoff, J. R. (2000) BIRinging chromosomes through cell division - And survivin' the experience, Cell 102, 545-548.
11. Wheatley, S. P., Carvalho, A., Vagnarelli, P., and Earnshaw, W. C. (2001) INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis, Curr. Biol. 11, 886-890.
12. Chen, J., Jin, S., Tahir, S. K., Zhang, H. C., Liu, X. S., Sarthy, A. V., McGonigal, T. P., Liu, Z. H., Rosenberg, S. H., and Ng, S. C. (2003) Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells, J. Biol. Chem. 278, 486-490.
13. Sun, C., Cai, M., Gunasekera, A. H., Meadows, R. P., Wang, H., Chen, J., Zhang, H., Wu. W., Xu, N., Ng, S. C., and Fesik, S. W. (1999) NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP, Nature 401, 818-822.
14. Sun, C., Cai, M., Meadows, R. P., Xu, N., Gunasekera, A. H., Herrmann, J., Wu, J. C., and Fesik, S. W. (2000) NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP, J. Biol. Chem. 275, 33777-33781.
15. Chantalat, L., Skoufias, D. A., Kleman, J. P., Jung, B., Dideberg, O., and Margolis, R. L. (2000) Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions, Mol. Cell 6, 183-189.
16. Muchmore, S. W., Chen, J., Jakob, C., Zakula, D., Matayoshi, E. D., Wu, W., Zhang, H. C., Li, F. Z., Ng, S. C., and Altieri, D. C. (2000) Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin, Mol. Cell 6, 173-182.
17. Verdecia, M. A., Huang, H. K., Dutil, E., Kaiser, D. A., Hunter, T., and Noel, J. P. (2000) Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 7, 602-608.
18. Shi, Y. G. (2000) Survivin structure: crystal unclear, Nat. Struct. Biol. 7, 620-623.
19. Cavanagh, J., Fairbrother, W. J., Palmer, A. G., and Skelton, N. J. (1996) Protein NMR spectroscopy. Principles and practice. Academic Press, Inc., San Diego, CA.
20. Clore, G. M., and Gronenborn, A. M. (1998) NMR structure determination of proteins and protein complexes larger than 20 kda, Curr. Opin. Chem. Biol. 2, 564-570.
21. 2H labeled proteins with high sensitivity, J. Am. Chem. Soc. 116, 11655-11666.
22. Neri, D., Szyperski, T., Otting, G., Senn, H., and Wuthrich, K. (1989) Stereospecific NMR assignment of Val and Leu Biochemistry 28, 7510-7516.
23. Brunger, A. T. (1992) X-PLOR Version 3.1, Yale University Press, New Haven.
24. Cornilescu, G., Delaglio, F., and Bax, A. (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology, J. Biomol. NMR 13, 289-302.
25. 1H NMR, Proteins 17, 297-309.
26. ODonoghue, S. I., King, G. F., and Nilges, M. (1996) Calculation of symmetric multimer structures from NMR data using a priori knowledge of the monomer structure, comonomer restraints, and interface mapping: The case of leucine zippers, J. Biomol. NMR 8, 193-206.
27. Goto, N. K., Gardner, K. H., Mueller, G. A., Willis, R. C., and Kay, L. E. (1999) A robust and cost-effective method for the production of Val, Leu, Ile methyl-protonated N-15-, C-13-, H-2-labeled proteins., J. Biomol. NMR 13(4), 369-374.
28. Hajduk, P. J., Augeri, D. J., Mack, J., Mendoza, R., Yang, J. G., Betz, S. F., and Fesik, S. W. (2000) NMR-based screening of proteins containing C-13-labeled methyl groups, J. Am. Chem. Soc. 122, 7898-7904.
29. Matsuo, H., Walters, K. J., Teruya, K., Tanaka, T., Gassner, G. T., Lippard, S. J., Kyogoku, Y., and Wagner, G. (1999) Identification by NMR spectroscopy of residues at contact surfaces in large, slowly exchanging macromolecular complexes, J. Am. Chem. Soc. 121, 9903-9904.
30. Wang, Z.-X. (1995) An exact mathematical expression for describing competitive binding of two different ligands to a protein, FEBS Lett. 360, 111-114.
31. Breeze, A. L. (2000) Isotope-filtered NMR methods for the study of biomolecular structure and interactions, Prog. Nucl. Magn. Reson. Spectrosc. 36, 323-372.
32. Fesik, S. W., and Zuiderweg, E. R. P. (1988) Heteronuclear Three-Dimensional NMR SPectroscopy. A Strategy for the Simplification of Homonuclear Two-Dimensional NMR Spectra. J. Magn. Reson. 78, 588-593.
33. Badran, A., Yoshida, A., Ishikawa, K., Goi, T., Yamaguchi, A., Ueda, T., and Inuzuka, M. (2004) Identification of a novel splice variant of the human anti-apoptosis gene survivin, Biochem. Biophys. Res. Commun. 314, 902-907.
34. Liu, Z., Sun, C., Olejniczak, E. T., Meadows, R. P., Betz, S. F., Oost, T., Herrmann, J., Wu, J. C., and Fesik, S. W. (2000) Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain, Nature. 408, 1004-1005.
35. Oost, T. K., Sun, C., Armstrong, R. C., Al-Assaad, A. S., Betz, S. F., Deckwerth, T. L., Ding, H., Elmore, S. W., Meadows, R. P., Olejniczak, E. T., Oleksijew, A., Oltersdorf, T., Rosenberg, S. H., Shoemaker, A. R., Tomaselli, K. J., Zou, H., and Fesik, S. W. (2004) Discovery of potent antagonists of the anti-apoptotic protein XIAP for the treatment of cancer. J. Med. Chem. 47, 4417-4426.
36. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) Procheck, J. Appl. Crystallogr. 26, 283-291.